Private equity investors are lobbying against the drug bill, telling Pelosi's staff the plan would dry up financing for small biotech firms.
Investors Fear Pelosi's Drug Price Plan
Comment
Show comments
Hide Comments
Private equity investors are lobbying against the drug bill, telling Pelosi's staff the plan would dry up financing for small biotech firms.
